Literature DB >> 16808729

Amphetamine neurotoxicity: cause and consequence of oxidative stress.

Bryan K Yamamoto1, Michael G Bankson.   

Abstract

Oxidative stress has been demonstrated to occur in response to high doses of substituted amphetamines such as methamphetamine (METH) and 3,4-methlyene-dioxymethamphetamine (MDMA). This term represents a set of complex and multi-faceted precursor events that occur in both a parallel and serial manner, eventually converging to produce oxidative damage. This critical review goes beyond the compilation of previously well-documented evidence demonstrating that oxidative stress mediates METH and MDMA toxicity to dopamine and/or serotonin nerve terminals. The diverse causes, effects, and impact of pro-oxidative processes produced by these drugs are highlighted, integrated, and assembled into a proposed temporal sequence in an effort to explain the long-term neurochemical changes produced by amphetamines. Multiple factors are considered, including dopamine, glutamate, impaired mitochondrial bioenergetics, and inflammatory processes, all of which converge and are necessary but alone may be insufficient to cause damage to dopamine and/or 5-HT terminals. In addition, the processes linking inflammation and oxidative stress are considered and described as a feedforward process. The self-perpetuating cycle of inflammation and oxidative stress that is initiated by dopamine, glutamate, and mitochondrial dysfunction may extend well beyond the acute pharmacodynamic effects of the drugs and could represent an underlying and potentially progressive degenerative process.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16808729     DOI: 10.1615/critrevneurobiol.v17.i2.30

Source DB:  PubMed          Journal:  Crit Rev Neurobiol        ISSN: 0892-0915


  61 in total

Review 1.  Mechanisms of MDMA (ecstasy)-induced oxidative stress, mitochondrial dysfunction, and organ damage.

Authors:  Byoung-Joon Song; Kwan-Hoon Moon; Vijay V Upreti; Natalie D Eddington; Insong J Lee
Journal:  Curr Pharm Biotechnol       Date:  2010-08       Impact factor: 2.837

2.  The role of endogenous serotonin in methamphetamine-induced neurotoxicity to dopamine nerve endings of the striatum.

Authors:  David M Thomas; Mariana Angoa Pérez; Dina M Francescutti-Verbeem; Mrudang M Shah; Donald M Kuhn
Journal:  J Neurochem       Date:  2010-09-06       Impact factor: 5.372

3.  Preliminary evaluation of a model of stimulant use, oxidative damage and executive dysfunction.

Authors:  Theresa Winhusen; Jessica Walker; Gregory Brigham; Daniel Lewis; Eugene Somoza; Jeff Theobald; Veronika Somoza
Journal:  Am J Drug Alcohol Abuse       Date:  2013-06-28       Impact factor: 3.829

4.  4-Methylmethcathinone (mephedrone): neuropharmacological effects of a designer stimulant of abuse.

Authors:  Gregory C Hadlock; Katy M Webb; Lisa M McFadden; Pei Wen Chu; Jonathan D Ellis; Scott C Allen; David M Andrenyak; Paula L Vieira-Brock; Christopher L German; Kevin M Conrad; Amanda J Hoonakker; James W Gibb; Diana G Wilkins; Glen R Hanson; Annette E Fleckenstein
Journal:  J Pharmacol Exp Ther       Date:  2011-08-02       Impact factor: 4.030

Review 5.  Nucleus accumbens invulnerability to methamphetamine neurotoxicity.

Authors:  Donald M Kuhn; Mariana Angoa-Pérez; David M Thomas
Journal:  ILAR J       Date:  2011

6.  PET studies of d-methamphetamine pharmacokinetics in primates: comparison with l-methamphetamine and ( --)-cocaine.

Authors:  Joanna S Fowler; Carsten Kroll; Richard Ferrieri; David Alexoff; Jean Logan; Stephen L Dewey; Wynne Schiffer; David Schlyer; Pauline Carter; Payton King; Colleen Shea; Youwen Xu; Lisa Muench; Helene Benveniste; Paul Vaska; Nora D Volkow
Journal:  J Nucl Med       Date:  2007-09-14       Impact factor: 10.057

7.  Connection between the striatal neurokinin-1 receptor and nitric oxide formation during methamphetamine exposure.

Authors:  Jing Wang; Wenjing Xu; Syed F Ali; Jesus A Angulo
Journal:  Ann N Y Acad Sci       Date:  2008-10       Impact factor: 5.691

8.  Dopamine disposition in the presynaptic process regulates the severity of methamphetamine-induced neurotoxicity.

Authors:  Donald M Kuhn; Dina M Francescutti-Verbeem; David M Thomas
Journal:  Ann N Y Acad Sci       Date:  2008-10       Impact factor: 5.691

9.  Cardiac effects of MDMA on the metabolic profile determined with 1H-magnetic resonance spectroscopy in the rat.

Authors:  Shane A Perrine; Mark S Michaels; Farhad Ghoddoussi; Elisabeth M Hyde; Manuel E Tancer; Matthew P Galloway
Journal:  NMR Biomed       Date:  2009-05       Impact factor: 4.044

10.  Higher diffusion in striatum and lower fractional anisotropy in white matter of methamphetamine users.

Authors:  Daniel Alicata; Linda Chang; Christine Cloak; Kylie Abe; Thomas Ernst
Journal:  Psychiatry Res       Date:  2009-09-26       Impact factor: 3.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.